Enteral Feeding Formulas Market: size, share, demand

1

• 12.7 Billion Enteral Feeding Formulas Market
  Meeting Nutritional Needs of 55.8 Million Seniors
  in the U.S
• The global enteral feeding formulas market has
  shown remarkable growth, reflecting an
  increasing demand for specialized nutritional
  solutions. Valued at 6.3 billion in 2022, it is
  projected to reach 12.7 billion by 2032,
  expanding at a CAGR of 7.4 from 2023 to 2032.
• This market caters to individuals unable to
  consume food orally due to various medical
  conditions, emphasizing the significance of
  enteral nutrition.
• Get a Sample Copy of this
• Report www.alliedmarketresearch.com/requestple/A
  11424
• Key Market Insights
• Growing Demand The increasing prevalence of
  chronic diseases such as neurological disorders,
  strokes, and cancer has become a significant
  driving force for the enteral feeding formulas
  market.
• Rising Preterm Birth Rates The global rise in
  preterm births necessitates specialized enteral
  feeding formulas for infants with underdeveloped
  digestive systems, further propelling market
  growth.
• Aging Population A notable increase in the
  geriatric population worldwide, which faces
  numerous health challenges that compromise their
  nutritional intake, is driving the demand for
  enteral feeding solutions.

2

• Market Dynamics
• Chronic Diseases Conditions such as cancer and
  strokes often hinder patients' ability to eat
  orally, leading to a heightened reliance on
  enteral nutrition.
• Cancer Statistics According to the American
  Cancer Society, oral cavity or oropharyngeal
  cancers were responsible for approximately 11,580
  deaths in the U.S. in 2023.
• Preterm Births The incidence of preterm births
  has been alarming, with rates ranging from 5 to
  18, especially in developing nations.
  Specialized formulas designed for preterm
  infants focus on providing essential nutrients
  crucial for their development.
• Geriatric Challenges As of 2021, over 55.8
  million adults aged 65 and older lived in the
  U.S., highlighting the critical need for
  nutritional solutions catering to this
  demographic.
• Challenges in the Market
• Patient Compliance One of the primary challenges
  is ensuring adherence to enteral feeding
  regimens. Factors such as the need for lifestyle
  adjustments and unappealing formula
  characteristics can lead to reduced compliance.
• Economic Pressures The 2023 recession has led to
  shifts in consumer spending habits, affecting
  the growth and innovation potential within the
  enteral feeding formulas market.

3

• Segment Overview
• By Product Type
• Standard formulas currently dominate the market
  however, disease-specific formulas are projected
  to grow rapidly due to the rising prevalence of
  chronic conditions.
• By Age Group
• Adult enteral feeding formulas have the highest
  revenue contribution, primarily due to the aging
  population and high chronic disease rates among
  adults.
• By Application
• The neurological disorders segment leads in
  revenue, while gastrointestinal disorders are
  anticipated to grow the fastest.
• By End-User

4

• The market features several key players,
  including Abbott Laboratories, Nestlé, Danone
• S.A, and Fresenius SE, which are focusing on
  product innovation and market expansion to
  enhance their competitive edge.
• Recent Developments
• In May 2022, Abbott announced a consent decree
  allowing limited releases of its EleCare
  specialty amino acid-based formulas.
• Meiji Holdings Co. Ltd launched new baby formulas
  aimed at emulating breast milk for optimal
  infant nutrition.
• Enquire about this report www.alliedmarketresearc
  h.com/purchasiry/A11424